- Home
- BRKR vs PCVX Comparison
BRKR vs PCVX Comparison
Compare BRKR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- PCVX
- Stock Information
- Founded
- BRKR 1991
- PCVX 2013
- Country
- BRKR United States
- PCVX United States
- Employees
- BRKR N/A
- PCVX N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BRKR Industrials
- PCVX Health Care
- Exchange
- BRKR Nasdaq
- PCVX Nasdaq
- Market Cap
- BRKR 9.2B
- PCVX 10.6B
- IPO Year
- BRKR 2000
- PCVX 2020
- Fundamental
- Price
- BRKR $60.07
- PCVX $88.17
- Analyst Decision
- BRKR Buy
- PCVX Strong Buy
- Analyst Count
- BRKR 13
- PCVX 9
- Target Price
- BRKR $76.00
- PCVX $149.38
- AVG Volume (30 Days)
- BRKR 1.4M
- PCVX 1.2M
- Earning Date
- BRKR 02-11-2025
- PCVX 02-25-2025
- Dividend Yield
- BRKR 0.33%
- PCVX N/A
- EPS Growth
- BRKR N/A
- PCVX N/A
- EPS
- BRKR 2.06
- PCVX N/A
- Revenue
- BRKR $3,241,300,000.00
- PCVX N/A
- Revenue This Year
- BRKR $15.23
- PCVX N/A
- Revenue Next Year
- BRKR $7.52
- PCVX N/A
- P/E Ratio
- BRKR $29.14
- PCVX N/A
- Revenue Growth
- BRKR 15.00
- PCVX N/A
- 52 Week Low
- BRKR $48.07
- PCVX $58.10
- 52 Week High
- BRKR $94.86
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BRKR 52.88
- PCVX 52.78
- Support Level
- BRKR $54.60
- PCVX $77.52
- Resistance Level
- BRKR $64.64
- PCVX $90.06
- Average True Range (ATR)
- BRKR 2.91
- PCVX 3.83
- MACD
- BRKR -0.16
- PCVX 0.93
- Stochastic Oscillator
- BRKR 54.48
- PCVX 84.93
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.